1. Home
  2. RAMP vs NVAX Comparison

RAMP vs NVAX Comparison

Compare RAMP & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LiveRamp Holdings Inc.

RAMP

LiveRamp Holdings Inc.

HOLD

Current Price

$37.41

Market Cap

1.7B

Sector

Technology

ML Signal

HOLD

Logo Novavax Inc.

NVAX

Novavax Inc.

HOLD

Current Price

$8.53

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RAMP
NVAX
Founded
2018
1987
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.5B
IPO Year
1994
1996

Fundamental Metrics

Financial Performance
Metric
RAMP
NVAX
Price
$37.41
$8.53
Analyst Decision
Buy
Hold
Analyst Count
5
9
Target Price
$35.60
$11.33
AVG Volume (30 Days)
1.8M
4.4M
Earning Date
05-20-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
22500.00
309.76
EPS
2.24
N/A
Revenue
$812,940,000.00
$1,123,479,000.00
Revenue This Year
$11.18
N/A
Revenue Next Year
$9.09
N/A
P/E Ratio
$16.71
N/A
Revenue Growth
9.03
64.69
52 Week Low
$21.71
$6.20
52 Week High
$37.92
$11.85

Technical Indicators

Market Signals
Indicator
RAMP
NVAX
Relative Strength Index (RSI) 68.08 40.85
Support Level $37.24 $7.94
Resistance Level $37.92 $9.02
Average True Range (ATR) 0.20 0.63
MACD -0.32 -0.09
Stochastic Oscillator 23.13 13.40

Price Performance

Historical Comparison
RAMP
NVAX

About RAMP LiveRamp Holdings Inc.

LiveRamp Holdings Inc is a technology company that helps companies build enduring brand and business value by collaborating responsibly with data. A groundbreaking leader in consumer privacy, data ethics, and foundational identity, LiveRamp offers a connected customer view with clarity and context while protecting brand and consumer trust. The Company provides a data collaboration platform, essentially acting as a data collaboration hub where businesses can securely share and manage first-party consumer data with trusted partners while prioritizing data privacy and ethics.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.

Share on Social Networks: